Alan S. Robertson
Leicester Royal Infirmary(GB)
Publications by Year
Research Areas
Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, HIV/AIDS Research and Interventions, Alzheimer's disease research and treatments, Computational Drug Discovery Methods
Most-Cited Works
- → Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects(2006)240 cited
- → Discovery of (S)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus(2011)115 cited
- → Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus(2011)68 cited
- → The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus(2012)44 cited
- → Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents(2017)40 cited
- → The Hepatoselective Glucokinase Activator PF-04991532 Ameliorates Hyperglycemia without Causing Hepatic Steatosis in Diabetic Rats(2014)38 cited
- → Highlights from the Canada Youth and AIDS Study(1989)35 cited
- → Identification and Preclinical Pharmacology of theγ-Secretase Modulator BMS-869780(2014)13 cited
- → Small molecule somatostatin receptor subtype-2 antagonists(2001)11 cited
- → Disorders of the Autonomic Nervous System(2019)10 cited